Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHP2 is a ubiquitously expressed cytosolic protein tyrosine phosphatase that plays a central role in cell signaling. It contains two N-terminal Src homology 2 (SH2) domains, a central catalytic phosphatase domain, and a C-terminal tail. The SH2 domains allow SHP2 to bind specifically to phosphorylated tyrosine residues on target proteins in response to various extracellular stimuli, modulating various signaling pathways involved in cell growth, differentiation, and immune responses. It is implicated in Noonan syndrome and various cancers.
Inhibition of SHP2 phosphatase activity, preventing dephosphorylation of target proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH2 Domain-Containing Protein Tyrosine Phosphatase (SHP2).